Global Trends and Hotspots on Microglia Associated with Pain from 2002 to 2022: A Bibliometric Analysis

References

• Raja SN, Carr DB, Cohen M, et al. The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–1982. doi:10.1097/j.pain.0000000000001939
   PubMed Web of Science ®Google Scholar
• Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006. doi:10.15585/mmwr.mm6736a2
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Peng J, Xu YN, et al. Microglia are indispensable for synaptic plasticity in the spinal dorsal horn and chronic pain. Cell Rep. 2019;27(13):3844–3859.e3846. doi:10.1016/j.celrep.2019.05.087
   PubMed Web of Science ®Google Scholar
• Tansley S, Gu N, Guzmán AU, et al. Microglia-mediated degradation of perineuronal nets promotes pain. Science. 2022;377(6601):80–86. doi:10.1126/science.abl6773
   PubMed Web of Science ®Google Scholar
• Schaible HG, König C, Ebersberger A. Spinal pain processing in arthritis: neuron and glia (inter)actions. J Neurochem. 2022. doi:10.1111/jnc.15742
   PubMed Web of Science ®Google Scholar
• Tsuda M, Masuda T, Kohno K. Microglial diversity in neuropathic pain. Trends Neurosci. 2023;46(7):597–610. doi:10.1016/j.tins.2023.05.001
   PubMed Web of Science ®Google Scholar
• Bossuyt J, Van Den Herrewegen Y, Nestor L, Buckinx A, De Bundel D, Smolders I. Chemogenetic modulation of astrocytes and microglia: state-of-The-art and implications in neuroscience. Glia. 2023;71:2071–2095. doi:10.1002/glia.24390
   PubMed Web of Science ®Google Scholar
• Sabe M, Pillinger T, Kaiser S, et al. Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev. 2022;136:104608. doi:10.1016/j.neubiorev.2022.104608
   PubMed Web of Science ®Google Scholar
• Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-9
   PubMed Web of Science ®Google Scholar
• Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003;424(6950):778–783. doi:10.1038/nature01786
   PubMed Web of Science ®Google Scholar
• Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438(7070):1017–1021. doi:10.1038/nature04223
   PubMed Web of Science ®Google Scholar
• Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003;306(2):624–630. doi:10.1124/jpet.103.052407
   PubMed Web of Science ®Google Scholar
• Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10(11):1361–1368. doi:10.1038/nn1992
   PubMed Web of Science ®Google Scholar
• Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10(1):23–36. doi:10.1038/nrn2533
   PubMed Web of Science ®Google Scholar
• Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 2005;28(2):101–107. doi:10.1016/j.tins.2004.12.002
   PubMed Web of Science ®Google Scholar
• Jin SX, Zhuang ZY, Woolf CJ, Ji RR. P38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci. 2003;23(10):4017–4022. doi:10.1523/JNEUROSCI.23-10-04017.2003
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107. doi:10.1016/0304-3959(88)90209-6
   PubMed Web of Science ®Google Scholar
• Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–110. doi:10.1016/0304-3959(83)90201-4
   PubMed Web of Science ®Google Scholar
• Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24(8):450–455. doi:10.1016/S0166-2236(00)01854-3
   PubMed Web of Science ®Google Scholar
• Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003;2(12):973–985. doi:10.1038/nrd1251
   PubMed Web of Science ®Google Scholar
• Milligan ED, Twining C, Chacur M, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003;23(3):1026–1040. doi:10.1523/JNEUROSCI.23-03-01026.2003
   PubMed Web of Science ®Google Scholar
• Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia. 2004;45(1):89–95. doi:10.1002/glia.10308
   PubMed Web of Science ®Google Scholar
• Ledeboer A, Sloane EM, Milligan ED, et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005;115(1–2):71–83. doi:10.1016/j.pain.2005.02.009
   PubMed Web of Science ®Google Scholar
• Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005;114(1–2):149–159. doi:10.1016/j.pain.2004.12.022
   PubMed Web of Science ®Google Scholar
• Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6(7):521–532. doi:10.1038/nrn1700
   PubMed Web of Science ®Google Scholar
• Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev. 2009;60(1):135–148. doi:10.1016/j.brainresrev.2008.12.011
   PubMedGoogle Scholar
• Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013;154(1):S10–s28. doi:10.1016/j.pain.2013.06.022
   PubMedGoogle Scholar
• Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 2013;716(1–3):106–119. doi:10.1016/j.ejphar.2013.01.072
   PubMed Web of Science ®Google Scholar
• Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14(4):217–231. doi:10.1038/nri3621
   PubMed Web of Science ®Google Scholar
• Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533–548. doi:10.1038/nrd4334
   PubMed Web of Science ®Google Scholar
• Sorge RE, Mapplebeck JC, Rosen S, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci. 2015;18(8):1081–1083. doi:10.1038/nn.4053
   PubMed Web of Science ®Google Scholar
• Guan Z, Kuhn JA, Wang X, et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci. 2016;19(1):94–101. doi:10.1038/nn.4189
   PubMed Web of Science ®Google Scholar
• Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354(6312):572–577. doi:10.1126/science.aaf8924
   PubMed Web of Science ®Google Scholar
• Inoue K, Tsuda M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat Rev Neurosci. 2018;19(3):138–152. doi:10.1038/nrn.2018.2
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018;100(6):1292–1311. doi:10.1016/j.neuron.2018.11.009
   PubMed Web of Science ®Google Scholar
• Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129(2):343–366. doi:10.1097/ALN.0000000000002130
   PubMed Web of Science ®Google Scholar
• Guo M, Li J, Sheng C, Xu J, Wu L. A review of wetland remote sensing. Sensors. 2017;17(4):1.
   Web of Science ®Google Scholar
• Luo H, Cai Z, Huang Y, et al. Study on pain catastrophizing from 2010 to 2020: a bibliometric analysis via CiteSpace. Front Psychol. 2021;12:759347. doi:10.3389/fpsyg.2021.759347
   PubMed Web of Science ®Google Scholar
• Biber K, Tsuda M, Tozaki-Saitoh H, et al. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011;30(9):1864–1873. doi:10.1038/emboj.2011.89
   PubMed Web of Science ®Google Scholar
• Masuda T, Iwamoto S, Yoshinaga R, et al. Transcription factor IRF5 drives P2X4R(+)-reactive microglia gating neuropathic pain. Nat Commun. 2014;5:11. doi:10.1038/ncomms4771
   Web of Science ®Google Scholar
• Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K. P2Y(12) receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci. 2008;28(19):4949–4956. doi:10.1523/JNEUROSCI.0323-08.2008
   PubMed Web of Science ®Google Scholar
• Tsuda M, Toyomitsu E, Komatsu T, et al. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia. 2008;56(5):579–585. doi:10.1002/glia.20641
   PubMed Web of Science ®Google Scholar
• Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain. 2007;3:9. doi:10.1186/1744-8069-3-33
   PubMed Web of Science ®Google Scholar
• Taves S, Berta T, Liu DL, et al. Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: sex-dependent microglial signaling in the spinal cord. Brain Behav Immun. 2016;55:70–81. doi:10.1016/j.bbi.2015.10.006
   PubMed Web of Science ®Google Scholar
• Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun. 2007;21(5):642–651. doi:10.1016/j.bbi.2006.11.003
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Zhang YN, Brown K, et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci. 2008;28(1):20–29. doi:10.1111/j.1460-9568.2008.06321.x
   PubMed Web of Science ®Google Scholar
• Lacagnina MJ, Watkins LR, Grace PM. Toll-like receptors and their role in persistent pain. Pharmacol Ther. 2018;184:145–158. doi:10.1016/j.pharmthera.2017.10.006
   PubMed Web of Science ®Google Scholar
• Lewis SS, Hutchinson MR, Rezvani N, et al. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1 beta. Neuroscience. 2010;165(2):569–583. doi:10.1016/j.neuroscience.2009.10.011
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Peng Y, et al. Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br J Pharmacol. 2016;173(5):856–869. doi:10.1111/bph.13394
   PubMed Web of Science ®Google Scholar
• Grace PM, Strand KA, Galer EL, et al. Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation. Proc Natl Acad Sci USA. 2016;113(24):E3441–E3450. doi:10.1073/pnas.1602070113
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Zhang YN, Shridhar M, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24(1):83–95. doi:10.1016/j.bbi.2009.08.004
   PubMed Web of Science ®Google Scholar
• Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21(2):131–146. doi:10.1016/j.bbi.2006.10.011
   PubMed Web of Science ®Google Scholar
• Watkins LR, Hutchinson MR, Milligan ED, Maier SF. “Listening” and “talking” to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev. 2007;56(1):148–169. doi:10.1016/j.brainresrev.2007.06.006
   PubMedGoogle Scholar
• Fan H, Li TF, Gong N, Wang YX. Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial beta-endorphin expression. Neuropharmacology. 2016;101:98–109. doi:10.1016/j.neuropharm.2015.09.010
   PubMed Web of Science ®Google Scholar
• Huang Q, Mao XF, Wu HY, et al. Cynandione A attenuates neuropathic pain through p38 beta MAPK-mediated spinal microglial expression of beta-endorphin. Brain Behav Immun. 2017;62:64–77. doi:10.1016/j.bbi.2017.02.005
   PubMed Web of Science ®Google Scholar
• Li TF, Fan H, Wang YX. Aconitum-derived bulleyaconitine A exhibits antihypersensitivity through direct stimulating dynorphin A Expression in spinal microglia. J Pain. 2016;17(5):530–548. doi:10.1016/j.jpain.2015.12.015
   PubMed Web of Science ®Google Scholar
• Li TF, Gong N, Wang YX. Ester hydrolysis differentially reduces aconitine-induced anti-hypersensitivity and acute neurotoxicity: involvement of spinal microglial dynorphin expression and implications for aconitum processing. Front Pharmacol. 2016;7:13. doi:10.3389/fphar.2016.00367
   Web of Science ®Google Scholar
• Sun ML, Ao JP, Wang YR, et al. Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression. Psychopharmacology. 2018;235(9):2559–2571. doi:10.1007/s00213-018-4948-y
   PubMed Web of Science ®Google Scholar
• Mohamed NS, Gwam CU, Etcheson JI, et al. Impact factors of orthopaedic journals between 2010 and 2016: trends and comparisons with other surgical specialties. Ann Transl Med. 2018;6(7):114. doi:10.21037/atm.2018.03.02
   PubMed Web of Science ®Google Scholar
• Tian H, Chen J. A bibliometric analysis on global eHealth. Digit Health. 2022;8:20552076221091352. doi:10.1177/20552076221091352
   Web of Science ®Google Scholar
• Wu Z, Cheng K, Shen Z, et al. Mapping knowledge landscapes and emerging trends of sonodynamic therapy: a bibliometric and visualized study. Front Pharmacol. 2022;13:1048211. doi:10.3389/fphar.2022.1048211
   PubMed Web of Science ®Google Scholar
• Hong ST, Youn HS. Status of editing and publishing of scholarly journals by academic societies of science and technology in Korea. J Korean Med Sci. 2020;35(25):e208. doi:10.3346/jkms.2020.35.e208
   PubMed Web of Science ®Google Scholar
• Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441–462. doi:10.1146/annurev.pa.20.040180.002301
   PubMed Web of Science ®Google Scholar
• McCleskey EW. Neurobiology: new player in pain. Nature. 2003;424(6950):729–730. doi:10.1038/424729a
   PubMed Web of Science ®Google Scholar
• Donnelly CR, Andriessen AS, Chen G, et al. Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics. 2020;17(3):846–860. doi:10.1007/s13311-020-00905-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang S, Li H, et al. Small-molecule modulators of toll-like receptors. Acc Chem Res. 2020;53(5):1046–1055. doi:10.1021/acs.accounts.9b00631
   PubMed Web of Science ®Google Scholar
• Huang J, Chai X, Wu Y, et al. β-Hydroxybutyric acid attenuates heat stress-induced neuroinflammation via inhibiting TLR4/p38 MAPK and NF-κB pathways in the hippocampus. FASEB J. 2022;36(4):e22264. doi:10.1096/fj.202101469RR
   PubMed Web of Science ®Google Scholar
• Chang S, Li X, Zheng Y, et al. Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF-ĸB signaling pathway. Phytother Res. 2022;36(4):1678–1691. doi:10.1002/ptr.7396
   PubMed Web of Science ®Google Scholar
• Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-like receptor 4 (TLR4)/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020;11:1455. doi:10.3389/fimmu.2020.01455
   PubMed Web of Science ®Google Scholar
• Luo L, Liu M, Fan Y, et al. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice. J Neuroinflammation. 2022;19(1):141. doi:10.1186/s12974-022-02501-2
   PubMed Web of Science ®Google Scholar
• Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337–352. doi:10.1111/bph.12139
   PubMed Web of Science ®Google Scholar
• Shin DA, Kim TU, Chang MC. Minocycline for controlling neuropathic pain: a systematic narrative review of studies in humans. J Pain Res. 2021;14:139–145. doi:10.2147/JPR.S292824
   PubMed Web of Science ®Google Scholar
• Yan B, Tang S, Zhang Y, Xiao X. The role of glia underlying acupuncture analgesia in animal pain models: a systematic review and meta-analysis. Pain Med. 2023;24(1):11–24. doi:10.1093/pm/pnac115
   PubMed Web of Science ®Google Scholar
• Pei P, Cui S, Zhang S, Hu S, Wang L, Yang W. Effect of electroacupuncture at fengchi on facial allodynia, microglial activation, and microglia-neuron interaction in a rat model of migraine. Brain Sci. 2022;12(8):1100. doi:10.3390/brainsci12081100
   PubMed Web of Science ®Google Scholar
• Ma X, Chen Y, Li XC, et al. Spinal neuronal GRK2 contributes to preventive effect by electroacupuncture on cisplatin-induced peripheral neuropathy in mice. Anesth Analg. 2022;134(1):204–215. doi:10.1213/ANE.0000000000005768
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou Y, Li XC, et al. Neuronal GRK2 regulates microglial activation and contributes to electroacupuncture analgesia on inflammatory pain in mice. Biol Res. 2022;55(1):5. doi:10.1186/s40659-022-00374-6
   PubMed Web of Science ®Google Scholar
• Fiore NT, Austin PJ. Glial-cytokine-neuronal adaptations in the ventral hippocampus of rats with affective behavioral changes following peripheral nerve injury. Neuroscience. 2018;390:119–140. doi:10.1016/j.neuroscience.2018.08.010
   PubMed Web of Science ®Google Scholar
• Barcelon EE, Cho WH, Jun SB, Lee SJ. Brain microglial activation in chronic pain-associated affective disorder. Front Neurosci. 2019;13:213. doi:10.3389/fnins.2019.00213
   PubMed Web of Science ®Google Scholar
• Albrecht DS, Kim M, Akeju O, et al. The neuroinflammatory component of negative affect in patients with chronic pain. Mol Psychiatry. 2021;26(3):864–874. doi:10.1038/s41380-019-0433-1
   PubMed Web of Science ®Google Scholar
• Inoue K. Microglial activation by purines and pyrimidines. Glia. 2002;40(2):156–163. doi:10.1002/glia.10150
   PubMed Web of Science ®Google Scholar
• Suurväli J, Boudinot P, Kanellopoulos J, Rüütel boudinot S. P2X4: a fast and sensitive purinergic receptor. Biomed J. 2017;40(5):245–256. doi:10.1016/j.bj.2017.06.010
   PubMed Web of Science ®Google Scholar
• Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci. 2009;29(11):3518–3528. doi:10.1523/JNEUROSCI.5714-08.2009
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu L, Xu D, et al. Interaction between astrocytic colony stimulating factor and its receptor on microglia mediates central sensitization and behavioral hypersensitivity in chronic post ischemic pain model. Brain Behav Immun. 2018;68:248–260. doi:10.1016/j.bbi.2017.10.023
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu B, Zhang N, et al. Spinal microglia-derived TNF promotes the astrocytic JNK/CXCL1 pathway activation in a mouse model of burn pain. Brain Behav Immun. 2022;102:23–39. doi:10.1016/j.bbi.2022.02.006
   PubMed Web of Science ®Google Scholar
• Li T, Liu T, Chen X, et al. Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain. J Neuroinflammation. 2020;17(1):211. doi:10.1186/s12974-020-01891-5
   PubMed Web of Science ®Google Scholar
• Blaszczyk L, Maître M, Lesté-Lasserre T, et al. Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation. J Neuroinflammation. 2018;15(1):349. doi:10.1186/s12974-018-1378-z
   PubMedGoogle Scholar
• Peng D, Wei J, Gan Y, et al. Testis developmental related gene 1 regulates the chemosensitivity of seminoma TCam-2 cells to cisplatin via autophagy. J Cell Mol Med. 2019;23(11):7773–7784. doi:10.1111/jcmm.14654
   PubMed Web of Science ®Google Scholar
• Liu X, Wang S, Zheng H, et al. Epimedokoreanin C, a prenylated flavonoid isolated from Epimedium koreanum, induces non-apoptotic cell death with the characteristics of methuosis in lung cancer cells. Am J Cancer Res. 2021;11(7):3496–3514.
   PubMed Web of Science ®Google Scholar
• Su SH, Wu YF, Lin Q, Wang DP, Hai J. URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion. J Neuroinflammation. 2019;16(1):260. doi:10.1186/s12974-019-1668-0
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi Y, Huang Y, et al. Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model. J Neuroinflammation. 2020;17(1):311. doi:10.1186/s12974-020-01991-2
   PubMed Web of Science ®Google Scholar
• Bai J, Geng B, Wang X, et al. Exercise facilitates the M1-to-M2 polarization of microglia by enhancing autophagy via the BDNF/AKT/mTOR pathway in neuropathic pain. Pain Phys. 2022;25(7):E1137–e1151.
   PubMed Web of Science ®Google Scholar
• Shao S, Xu CB, Chen CJ, et al. Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice. J Neuroinflammation. 2021;18(1):142. doi:10.1186/s12974-021-02178-z
   PubMed Web of Science ®Google Scholar
• Cai W, Zhang Y, Su Z. ciRS-7 targeting miR-135a-5p promotes neuropathic pain in CCI rats via inflammation and autophagy. Gene. 2020;736:144386. doi:10.1016/j.gene.2020.144386
   PubMed Web of Science ®Google Scholar
• Liao MF, Lu KT, Hsu JL, Lee CH, Cheng MY, Ro LS. The role of autophagy and apoptosis in neuropathic pain formation. Int J Mol Sci. 2022;23(5):2685. doi:10.3390/ijms23052685
   PubMed Web of Science ®Google Scholar
• Qiao LY, Tiwari N. Spinal neuron-glia-immune interaction in cross-organ sensitization. Am J Physiol Gastrointest Liver Physiol. 2020;319(6):G748–g760. doi:10.1152/ajpgi.00323.2020
   PubMed Web of Science ®Google Scholar
• Xia LP, Luo H, Ma Q, et al. GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation. Brain. 2021;144(11):3405–3420. doi:10.1093/brain/awab245
   PubMedGoogle Scholar
• Song L, Liang J, Wang W, et al. Global trends in research of mitochondrial biogenesis over past 20 years: a bibliometric analysis. Oxid Med Cell Longev. 2023;2023:7291284. doi:10.1155/2023/7291284
   PubMed Web of Science ®Google Scholar